A woman has filed a talcum powder lawsuit against Johnson & Johnson, alleging the pharmaceutical giant failed to warn women about the potential risks associated with using their products containing talc. The plaintiff claims she used the products regularly for many years, leading to a diagnosis of ovarian cancer in... Read more »

A teenager has been awarded $70 million by a jury in his Risperdal lawsuit – the largest jury award to date involving Risperdal litigation. The plaintiff and his mother allege use of Risperdal for a number of years during childhood led to the growth of male breasts, a condition known... Read more »

Defendants Johnson & Johnson allegedly ignored the link between long-term talc powder use and ovarian cancer, claims a new joint lawsuit filed by 10 plaintiffs. The plaintiffs include six families of women who lost their lives to ovarian cancer that was allegedly caused by the long-term use of talc for... Read more »

A judge in St. Louis, Missouri ordered Johnson & Johnson to pay plaintiff Gloria Ristesund $55 million in damages for allegedly “failing to warn consumers of known risks” associated with their talcum powder – the second verdict of its kind, to date. In February, the same court awarded $72 million to the... Read more »

Xarelto, a highly touted alternative to the blood-thinning medication Warfarin, has come under fire with questions about the clinical trial that led to its approval. Faulty equipment used to monitor some of the patients in the trial may have contributed to results that made Xarelto look superior to warfarin, leading... Read more »

A Missouri jury has awarded $72 million to the family of a woman after determining her ovarian cancer was directly linked to decades of use of talcum powder products manufactured by Johnson & Johnson. The verdict was the first to award damages to a plaintiff after determining the pharmaceutical giant... Read more »

An appeal by Johnson & Johnson to overturn a $124 million verdict against the company has been rejected by the U.S. Supreme Court. The verdict involved the pharmaceutical giant’s drug Risperdal, an atypical antipsychotic the state of South Carolina alleged was illegally marketed by the company. Lawsuit alleges deceptive marketing... Read more »

The drug Invokana belongs to a class of Type II diabetes medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, and is referred to generically as canagliflozin. This class of drugs, which also includes well-known brands like Farxiga, Xigdua XR, Jardiance and Glyxambi, was once highly-touted as an innovative alternative for Type II... Read more »

A settlement has been reached between the Kentucky Attorney General and Johnson & Johnson regarding the schizophrenia drug Risperdal. The lawsuit was originally filed with allegations that the pharmaceutical giant and its subsidiary Janssen Pharmaceuticals hid some of the drug’s side effects from consumers, while marketing it for off-label use... Read more »

A man has been awarded $1.75 million by a jury that determined his breast growth was caused by his use of Risperdal as a child. This is the fourth trial involving the link between Risperdal and male breast growth. The first two also resulted in decisions favoring the plaintiffs and the... Read more »